Skip to main content

Table 5 Clinical profile differences and second-generation antihistamine usage based on collective experiences of clinicians surveyed

From: Selecting optimal second-generation antihistamines for allergic rhinitis and urticaria in Asia

 

Bilastine

Cetirizine

Desloratadine

Fexofenadine

Levocetirizine

Loratadine

Rupatadinea

Indicated for:

 Allergic rhino-conjunctivitis

X

X

X

 Urticaria

 Allergic rhinitis

Most frequently prescribed for allergic rhinitis

Cetirizine

Most frequently prescribed for urticaria

Cetirizine

Levocetirizine

Observations on efficacy

Excellent

Good

Fair/good

Excellent

Excellent

Good

Good

Commonly prescribed daily dose

20 mg OD

10 mg OD

5 mg OD

180 mg OD

5 mg OD

10 mg OD

10 mg OD

Duration of treatment

2 weeks and above (depending on severity of symptoms)

Dose adjustment requirements

None

Severe renal impairment

Severe renal impairment

None

Severe renal impairment

Severe hepatic impairment

None

Contraindications and adverse effects

None

Severe renal impairment

Sedation

None

Light sedation

None

Very occasional worsening (could be due to allergy to dye of pill)

Severe renal impairment

Light sedation

None

Sedation

Interaction with ketoconazole, erythromycin, and statins

  1. Data based on United Kingdom SmPCs and/or clinician survey. In some APAC countries, only certain formulations of cetirizine are approved for allergic rhinoconjunctivitis
  2. OD once daily
  3. aRupatadine is not available in Malaysia and was only recently introduced into the Philippines and Thailand; hence, experience using this drug may be limited